Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients

Oct. 30, 2017

Immunocore presents constructs for treating HIV infection and AIDS

Oct. 25, 2017

Population Council initiates phase I study of griffithsin gel for HIV prevention

Oct. 23, 2017

EC approves Symtuza for HIV-1 in adolescents and adults, NDA filed in U.S.

Sep. 26, 2017

Grant supports IBBR's development of multispecific antibody as therapeutic for HIV

Sep. 6, 2017

GlaxoSmithKline, ViiV identify new HIV allosteric integrase inhibitors

Sep. 5, 2017

ViiV Healthcare divulges new HIV maturation inhibitors

Aug. 24, 2017

GlaxoSmithKline identifies novel ingenol derivatives

Aug. 16, 2017

EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate

Aug. 11, 2017

FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV

Aug. 11, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026